T1	intervention 9 22	web-based app
T2	No-of-participants 744 754	Forty-four
T3	eligibility 755 817	women with early-stage breast cancer and a new AI prescription
T4	control 896 920	App (no reminders) group
T6	outcome 1040 1061	weekly app usage rate
T7	intervention-value 1063 1065	74
T8	control-value 1070 1073	38%
T9	outcome 1129 1141	AI adherence
T10	intervention-value 1154 1157	100
T11	control-value 1162 1165	72%
T12	outcome 1178 1201	Symptom burden increase
